Cargando…
Pharmacologic Activation of p53 Triggers Viral Mimicry Response Thereby Abolishing Tumor Immune Evasion and Promoting Antitumor Immunity
The repression of repetitive elements is an important facet of p53's function as a guardian of the genome. Paradoxically, we found that p53 activated by MDM2 inhibitors induced the expression of endogenous retroviruses (ERV) via increased occupancy on ERV promoters and inhibition of two major E...
Autores principales: | Zhou, Xiaolei, Singh, Madhurendra, Sanz Santos, Gema, Guerlavais, Vincent, Carvajal, Luis A., Aivado, Manuel, Zhan, Yue, Oliveira, Mariana M.S., Westerberg, Lisa S., Annis, D. Allen, Johnsen, John Inge, Selivanova, Galina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414294/ https://www.ncbi.nlm.nih.gov/pubmed/34230007 http://dx.doi.org/10.1158/2159-8290.CD-20-1741 |
Ejemplares similares
-
Mutant p53 gain of function mediates cancer immune escape that is counteracted by APR-246
por: Zhou, Xiaolei, et al.
Publicado: (2022) -
Inhibition of p53 inhibitors: progress, challenges and perspectives
por: Sanz, Gema, et al.
Publicado: (2019) -
First in class dual MDM2/MDMX inhibitor ALRN-6924 enhances antitumor efficacy of chemotherapy in TP53 wild-type hormone receptor-positive breast cancer models
por: Pairawan, Seyed, et al.
Publicado: (2021) -
Reactive Oxygen Species and Antitumor Immunity—From Surveillance to Evasion
por: Kotsafti, Andromachi, et al.
Publicado: (2020) -
The schedule of ATR inhibitor AZD6738 can potentiate or abolish antitumor immune responses to radiotherapy
por: Vendetti, Frank P., et al.
Publicado: (2023)